{
  "meta": {
    "title": "Rheumatoid_Arthritis_Sjogren_Scleroderma_Inflammatory_Myopathy",
    "url": "https://brainandscalpel.vercel.app/rheumatoid-arthritis-sjogren-scleroderma-inflammatory-myopathy-8326b286.html",
    "scrapedAt": "2025-11-30T08:49:18.148Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Systemic lupus erythematosus</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Dermatomyositis</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Sjogren syndrome</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Scleroderma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40 years old female presents with malar rash involving nasolabial fold and gradually progressive proximal muscle weakness. Serum creatine phosphokinase is more than 2000 IU/L. Immunological work up shows and Anti Mi2 antibody is high titer positive. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1295563",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295563,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Diagnosis is dermatomyositis-hints for diagnosis:</strong></p>\r\n<ul>\r\n<li>Skin rash-malar rash with involvement of nasolabial fold (in contrast to SLE where nasolabial fold is spared)</li>\r\n<li>Prominent progressive proximal muscle weakness</li>\r\n<li>Antibody positive-Mi2+ is a myositis specific antibody and its high titer confirms the diagnosis of myositis.</li>\r\n</ul>\r\n<p><strong>Dermatomyositis: </strong></p>\r\n<ul>\r\n<li>DM manifests with symmetric, proximal greater than distal weakness</li>\r\n<li>Various clinical findings in dermatomyositis:</li>\r\n<li><strong>Heliotrope rash:</strong> erythematous discoloration of eyelids with periorbital oedema</li>\r\n<li>Gottron sign: erythematous rash over the extensor surfaces of joints such as the knuckles, elbows, knees, and ankles</li>\r\n<li>Gottron papules: raised erythematous rash over knuckles.</li>\r\n<li>V-sign: rash on the sun-exposed anterior neck and chest</li>\r\n<li>Shawl sign over the back of the neck and shoulders, nail bed telangiectasias, and sub-cutaneous calcium deposits.</li>\r\n</ul>\r\n<p><strong>Other Manifestations in Dermatomyositis:</strong></p>\r\n<ul>\r\n<li>Dyspnea can occur from ventilatory muscle weakness or intrinsic pulmonary problems including interstitial lung disease (ILD), bronchopneumonia, and alveolitis.</li>\r\n<li>There is a higher risk<strong> for malignancy in adult-onset cases, ~15% within the first 2-3 years.</strong></li>\r\n</ul>\r\n<p><strong>Laboratory Findings:</strong></p>\r\n<ul>\r\n<li>Elevated serum creatine phosphokinase-seen in 70-80% patients.</li>\r\n<li>Elevated serum Lactate dehydrogenase and aldolase.</li>\r\n<li>Electromyography shows myopathic pattern.</li>\r\n</ul>\r\n<p><strong>Presence of Myositis specific Antibodies:</strong> Dermatomyositis is associated with several MSA targeting melanoma differentiation antigen 5 (MDA5), transcriptional intermediary factor 1 (TIF1), Mi-2, and nuclear matrix protein 2</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011055cdb740-f33b-4fe5-a7d0-1fe98e6c7dfb.jpg\">\r\n \r\n ",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Polymyositis</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Rhabdomyolysis</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Dermatomyositis</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40 years old male presented with insidious onset progressive muscle weakness for last 6 months. There is no family history of similar illness, no fever or skin rash. Evaluation shows power of proximal muscles is significantly reduced in all 4 limbs, EMG s myopathic pattern, serum CPK is 16000 IU/L, Renal function, serum calcium, phosphate and potassium is normal. Myositis profile is positive for SRP antibody. What is the likely diagnosis?</span></p>",
      "unique_key": "DT1295944",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295944,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Although CPK is significantly raised but renal function, Serum potassium, phosphate is normal. Hence Rhabdomyolysis is unlikely.</li>\r\n<li>There is no history of skin rash hence dermatomyositis cannot be diagnosed.</li>\r\n<li>There is no comment regarding history of hypothyroidism or no mention of TSH. In hypothyroidism proximal muscle weakness can occur. But information is not adequate to make the diagnosis of hypothyroidism.</li>\r\n<li>Polymyositis is most likely diagnosis:</li>\r\n<li>Hints for diagnosis of Polymyositis: <strong>proximal muscle weakness</strong> that is <strong>insidious onset and slowly progressive</strong>. Serum CPK is raised indicating muscle injury and SRP (Which is a myosotis specific antibody) is present. These are sufficient to make the diagnosis of polymyositis.</li>\r\n</ul>\r\n<p><strong>Must know facts about Polymyositis:</strong></p>\r\n<ol>\r\n<li>Insidious onset progressive muscle weakness of all 4 limbs.</li>\r\n<li>There can be extra-muscular manifestations like involvement of heart, lungs and joints.</li>\r\n<li>There is increased risk of cancer as compared to general population but it is less as compared to dermatomyositis.</li>\r\n<li>Creatinine kinase is always raised in controlled Polymyositis.</li>\r\n<li>Nonspecific inflammatory cells present in perimysial more often than endomysial locations in PM.</li>\r\n<li>Myositis specific antibodies that present with polymyositis include Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) and anti-signal recognition particle (SRP) antibodies</li>\r\n</ol>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250110c0d098ca-5477-4185-86bd-043326aed940.jpg\">\r\n ",
      "correct_choice_id": 11,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Dermatomyositis</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Polymyositis</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Inclusion Body myositis</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Statin Induced Myopathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">cN-1A antibody is seen in which of the following myopathy/myopathies?</span></p>",
      "unique_key": "DT1295945",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295945,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>cN-1A, cytosolic 5'-nucleotidase 1A is a myositis specific antibody seen in up-to 1/3<sup>rd</sup> cases of inclusion body myositis.</p>\r\n<ul>\r\n<li>IBM usually manifests in patients over the age of 50 years and is slightly more common in men than women.</li>\r\n<li>Slowly progressive weakness and muscle atrophy that has a predilection for <strong>early involvement of the wrist and finger flexors in the arms and quadriceps in the legs. Dysphagia is common</strong></li>\r\n<li><strong>Laboratory Features:</strong> CK levels can be normal or only slightly elevated (usually &lt;10 times normal).</li>\r\n<li>Antibodies targeting cytosolic 5'-nucleotidase 1A (cN-1A) are detected in the blood in a third to more than two-thirds of IBM patients and are a highly specific diagnostic biomarker for IBM.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501105381039f-c0c7-4382-ad43-09ec2dfb387e.jpg\">\r\n ",
      "correct_choice_id": 23,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Myositis</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Malar rash</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Interstitial lung disease</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-erosive arthritis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a classic feature of anti-synthetase syndrome?</span></p>",
      "unique_key": "DT1295946",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295946,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Anti-synthetase syndrome:</strong></p>\r\n<ul>\r\n<li>Classical components include myositis, nonerosive arthritis, ILD, Raynaud's phenomenon, mechanic hands, and fever.</li>\r\n<li>Antibodies against aminoacyl-tRNA synthetase.</li>\r\n<li>Histopathologic features of DM, which likely accounts for many of these patients being classified as having DM.</li>\r\n<li><strong>The most common aminoacyl-tRNA synthetase antibody is anti-Jo-1.</strong></li>\r\n<li>CK is usually elevated in patients with AS and myositis. Those with ILD demonstrate reduced forced vital capacity and diffusion capacity on pulmonary function tests.</li>\r\n</ul>\r\n<p><strong>Drug induced myopathy</strong></p>\r\n<p><strong>Following drugs are known to cause muscle weakness</strong></p>\r\n<ul>\r\n<li>Chloroquine</li>\r\n<li>Hydroxychloroquine</li>\r\n<li>Statins</li>\r\n<li>Colchicine</li>\r\n<li>Zidovudine</li>\r\n<li>Corticosteroids</li>\r\n<li>Alcohol</li>\r\n<li>Myositis associated with checkpoint inhibitors like ipilimumab</li>\r\n</ul>\r\n ",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypercalcemia</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Reynaud phenomenon</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Oesophageal dysmotility</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Telangiectasia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a feature of CREST syndrome?</span></p>",
      "unique_key": "DT1295947",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295947,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Systemic sclerosis is a systemic autoimmune Rheumatic disease characterized by skin thickening.</li>\r\n<li>Depending on the pattern of involvement there are two morphological forms of systemic sclerosis-diffuse type when skin involvement extends proximal to elbow joint. While in case of localised systemic sclerosis skin induration is restricted distal to elbow joint with involvement of face.</li>\r\n<li>CREST Syndrome - is a subset of limited cutaneous systemic sclerosis with characteristic manifestations that include:\r\n<ul>\r\n<li>calcinosis cutis</li>\r\n<li>Raynaud's phenomenon</li>\r\n<li>Esophageal dysmotility</li>\r\n<li>Sclerodactyly,</li>\r\n<li>and telangiectasia</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p>In some patients, Raynaud's phenomenon and characteristic clinical and laboratory features of SSc occurs in the absence of detectable skin thickening. This relatively benign disease subset has been termed <strong>SSc sine scleroderma.</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011036f617ba-bff0-46b0-8ee4-98038b32edc8.jpg\">\r\n ",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Topoisomerase antibody</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-centromere antibody</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">RNA polymerase III</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Ani-Ribosomal P</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following antibody is seen in systemic sclerosis except?</span></p>",
      "unique_key": "DT1295948",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295948,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Various scleroderma associated antibodies include the following: </strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250110761c99e0-97a0-47a5-92c5-162687de6d72.jpg\">\r\n ",
      "correct_choice_id": 54,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium channel blockers</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Clonidine</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Angiotensinogen converting enzyme inhibitors</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta blockers</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is Drug of choice for management of scleroderma renal crisis?</span></p>",
      "unique_key": "DT1295949",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295949,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Scleroderma Renal Crisis (SRC)</strong></p>\r\n<ul>\r\n<li>Life threatening complication of systemic sclerosis</li>\r\n<li>Risk factors for development - early disease (&lt;4 years of disease onset), RNA polymerase III antibody (seen in 50% cases of SRC), Use of glucocorticoids (&gt;10 mg/day)</li>\r\n<li>Clinical features include - accelerated hypertension and progressive oliguric renal insufficiency.</li>\r\n<li><strong>ACE inhibitors are the drug of choice. </strong></li>\r\n<li>SRC mimics Thrombotic Thrombocytopenic purpura (TTP) BUT in SRC serum level of ADAMTS13 is normal while in TTP it is &lt;10%.</li>\r\n</ul>\r\n<p><strong>Other Clinical Manifestations of Scleroderma include:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250110f55401ac-20e5-4ee6-978a-dc8d409e9753.jpg\">\r\n ",
      "correct_choice_id": 63,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Tadalafil</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Nifedipine</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Prazosin</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoprolol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following drugs are useful for management of Raynaud's phenomenon except?</span></p>",
      "unique_key": "DT1295950",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295950,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Raynaud Phenomenon</strong></p>\r\n<ul>\r\n<li>Characterized by episodic vasoconstriction in the fingers and toes. Attacks are reversible, and can be triggered by a decrease in temperature, as well as emotional stress and vibration.</li>\r\n<li>It is the most frequent extracutaneous complication of SSc.</li>\r\n<li>Attacks typically start with pallor of the fingers, followed by cyanosis of variable duration. Hyperaemia ensues spontaneously or with rewarming of the digit.</li>\r\n<li><strong>It can be Primary or Secondary</strong></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250110120c9613-8ea3-45cf-9d42-4c48f72462b2.jpg\">\r\n<p><strong>Drugs useful for management of Raynaud's Phenomenon:</strong></p>\r\n<ul>\r\n<li>Extended-release dihydropyridine calcium channel blockers such as e.g. amlodipine and nifedipine, as well as diltiazem</li>\r\n<li>Angiotensin II receptor blockers such as losartan are effective (ACE inhibitors do not reduce the frequency or severity of episodes)</li>\r\n<li>&alpha;1-adrenergic receptor blockers (e.g., prazosin)</li>\r\n<li>Phosphodiesterase-5 inhibitors (e.g., sildenafil)</li>\r\n<li>Topical nitro-glycerine</li>\r\n<li>Intermittent IV infusions of prostaglandins.</li>\r\n</ul>\r\n<p><strong>Beta Blockers are themselves associated with Raynaud's Phenomenon.</strong></p>\r\n ",
      "correct_choice_id": 74,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Systemic lupus erythematosus.</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Rheumatoid arthritis</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Systemic sclerosis</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Leprosy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">40 years old female presents with pain, swelling and deformity of small joints of hands for last 2 years. Examination reveals swan neck deformity. On investigation rheumatoid factor and anti-CCP is high titer positive. what is the most likely diagnosis?</span></p>",
      "unique_key": "DT1295951",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295951,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Inflammatory polyarthritis (pain and swelling of 5 or more joints), presence of <strong>swan neck deformities and high titer rheumatoid factor and anti-CCP positivity</strong> is sufficient to make the diagnosis of rheumatoid arthritis.</li>\r\n</ul>\r\n<p><strong>Clinical features of Rheumatoid arthritis</strong></p>\r\n<ul>\r\n<li>Most common age - 25 and 55 years</li>\r\n<li>Most common symptom - pain and swelling of multiple joints with early morning stiffness greater than 1 hour and it improves with activity.</li>\r\n<li>The initial pattern of joint involvement may be monoarticular, oligoarticular (&le;4 joints), or polyarticular (&gt;5 joints), usually in a <strong>symmetric</strong></li>\r\n<li>Wrists and metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints stand out as the most frequently involved joints. Distal interphalangeal joint involvement is rare in rheumatoid arthritis.</li>\r\n</ul>\r\n<p><strong>Extraarticular involvement-depicted in image below</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250110fe225872-57fc-4e4c-b369-df4eaeb64456.jpg\">\r\n ",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Swan neck deformity</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Z deformity</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Boutonniere deformity</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following deformities is seen in Rheumatoid arthritis?</span></p>",
      "unique_key": "DT1295952",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295952,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Deformities in rheumatoid arthritis</strong></p>\r\n<ul>\r\n<li>Ulnar deviation results from subluxation of the MCP joints, with subluxation, or partial dislocation, of the proximal phalanx to the volar side of the hand.</li>\r\n<li>Swan-neck deformity: Hyperextension of the PIP joint with flexion of the DIP joint</li>\r\n<li>Boutonniere deformity: flexion of the PIP joint with hyperextension of the DIP joint</li>\r\n<li>Z-line deformity: subluxation of the first MCP joint with hyperextension of the first interphalangeal (IP) joint</li>\r\n<li><strong>\"piano-key movement\" of the ulnar styloid:</strong> Inflammation about the ulnar styloid and tenosynovitis of the extensor carpi ulnaris may cause subluxation of the distal ulna</li>\r\n<li>Flat feet - Although metatarsophalangeal (MTP) joint involvement in the feet is an early feature of disease, chronic inflammation of the ankle and midtarsal regions usually comes later and may lead to pesplanovalgus (\"flat feet\").</li>\r\n</ul>\r\n ",
      "correct_choice_id": 94,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Systemic lupus erythematosus</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Sjogren syndrome</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Rheumatoid arthritis</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Felty syndrome is seen in which of the following rheumatological disease?</span></p>",
      "unique_key": "DT1295954",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295954,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Felty syndrome is a complication of rheumatoid arthritis</strong></p>\r\n<p>Felty's syndrome is defined by the <strong>clinical triad of neutropenia, splenomegaly, and nodular RA</strong> and is seen in &lt;1% of patients. It typically occurs in the late stages of severe RA.</p>\r\n<p>T-cell large granular lymphocyte leukemia (T-LGL) may have a similar clinical presentation and often occurs in association with RA. T-LGL is characterized by a chronic, indolent clonal growth of LGL cells, leading to <strong>Neutropenia and splenomegaly.</strong> As opposed to Felty's syndrome, T-LGL may develop early in the course of RA.</p>\r\n<p>Must know facts about extraarticular manifestations of rheumatoid arthritis</p>\r\n<ol>\r\n<li><strong>Rheumatoid nodules are subcutaneous nodule</strong>. Accelerated nodule formation can be seen in RA patients on methotrexate.</li>\r\n<li><strong>Pleuritis or pleural effusion</strong> is most common pulmonary manifestation. Interstitial lung disease can be seen. Usual interstitial pneumonia is most common ILD in RA followed by NSIP.</li>\r\n<li><strong>Pericarditis or pericardial effusion is most common cardiac manifestation.</strong></li>\r\n<li>Increased risk of lymphoma - <strong>diffuse large B cell lymphoma</strong> is the most common type.</li>\r\n<li>Increased risk of cardiovascular disease and osteoporosis</li>\r\n</ol>\r\n ",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Rheumatoid factor</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-CCP</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-SSA antibody</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-histone antibody</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following antibody is most specific for diagnosis of rheumatoid arthritis?</span></p>",
      "unique_key": "DT1295958",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295958,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011019c9e08f-921c-4da7-85a1-76b032646e85.jpg\">\r\n<p>Option C: Anti SSA antibody is used in the diagnosis of primary Sjogren syndrome and Anti-histone antibody is seen in Systemic Lupus Erythematosus.</p>\r\n<p><strong>Other laboratory and Radiological investigation in RA:</strong></p>\r\n<ul>\r\n<li>Up-to 30% can have positive Antinuclear antibody and anti-neutrophil cytoplasmic antibodies</li>\r\n<li>Raised inflammatory markers like raised ESR and C-reactive protein</li>\r\n<li>synovial fluid analysis-total leucocyte count 5000-50000/uL. (&lt;2000/uL in osteoarthritis.)</li>\r\n<li>Plain Radiography Classically in RA, the initial radiographic finding is periarticular osteopenia. soft tissue swelling, symmetric joint space loss, and subchondral erosions, most frequently in the wrists and hands (MCPs and PIPs) and the feet (MTPs). In the feet, the lateral aspect of the fifth MTP is often targeted first, but other MTP joints may be involved at the same time.</li>\r\n<li>MRI: Presence of bone marrow edema has been recognized to be an early sign of inflammatory joint disease and can predict the subsequent development of erosions on plain radiographs as well as MRI scans.</li>\r\n<li>Ultrasound, including power color Doppler, can detect more erosions than plain radiography.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Duration of symptoms</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Presence or absence of Rheumatoid factor and Anti-CCP.</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Raised inflammatory markers</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Presence or absence of fever.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following features are included in the most updated ACR/EULAR classification criteria for Rheumatoid arthritis except?</span></p>",
      "unique_key": "DT1295961",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295961,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>6 or more points is required for classification as Rheumatoid arthritis.</strong></li>\r\n<li>This is a classification criteria and is primarily used in the clinical trials although it is used by primary care physicians to make the diagnosis of RA.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501108fbebbe1-3b63-4ade-9e83-e002668e409b.jpg\">\r\n ",
      "correct_choice_id": 124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Rituximab</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Tocilizumab</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Adalimumab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are considered biological Disease modifying anti-rheumatic drugs for management of Rheumatoid arthritis except?</span></p>",
      "unique_key": "DT1295963",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295963,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Disease modifying Anti-rheumatic drugs are mainly used for management of Rheumatoid arthritis.</p>\r\n<ul>\r\n<li>Corticosteroids, NSAIDS are mainly used for symptomatic control.</li>\r\n<li>DMARDs are classified into two major groups:</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250110240cb60c-07a8-481a-bac9-f0f1d6d9c19c.jpg\">\r\n<p><strong>Janus Kinase Inhibitors like Tofacitinib, Upadacitinib, Baricitinib. These are called as targeted synthetic DMARDs.</strong></p>\r\n<p>Tofacitinib is a selective JAK1 and JAK3 inhibitor with minor inhibitory effects on JAK2 and Tyk2, whereas baricitinib is a selective JAK1 and JAK2 inhibitor with moderate inhibition of Tyk2 and minimal inhibition of JAK3. Upadacitinib is a predominately selective inhibitor of JAK1.</p>\r\n ",
      "correct_choice_id": 131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydroxychloroquine</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Sulfasalazine</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drug/drugs is teratogenic and hence should not be used to treat Rheumatoid arthritis during pregnancy?</span></p>",
      "unique_key": "DT1295964",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295964,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Must remember that RA disease activity improves during Pregnancy.</li>\r\n<li>Up to 75% of female RA patients will note overall improvement in symptoms during pregnancy but often will flare after delivery.</li>\r\n<li>Flares during pregnancy are generally treated with low doses of prednisone; hydroxychloroquine and sulfasalazine are probably the safest DMARDs to use during pregnancy.</li>\r\n<li>Methotrexate and leflunomide therapy are contraindicated during pregnancy due to their teratogenicity in animals and humans. In general, biologics are thought to be safe through the second trimester</li>\r\n</ul>\r\n ",
      "correct_choice_id": 143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Group A streptococcus</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Group C streptococcus</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Group G streptococcus</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following organism is definite etiological agent for Acute Rhematic fever?</span></p>",
      "unique_key": "DT1295965",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295965,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>ARF is exclusively caused by infection of the upper respiratory tract with <strong>group A streptococci</strong>. Although classically, certain M-serotypes (particularly types 1, 3, 5, 6, 14, 18, 19, 24, 27, and 29) were associated with ARF, recent evidence demonstrates that many more M-serotypes are rheumatogenic and that so-called \"rheumatogenic motifs\" are found in only a minority of serotypes associated with rheumatic fever.</p>\r\n<p>This epidemiologic evidence also points to a clear role of skin infection in the pathogenesis of ARF. <strong>The potential role of groups C and G streptococci is unclear at this time.</strong></p>\r\n<p>There is a latent period of ~3 weeks (1-5 weeks) between the precipitating group A streptococcal infection and the appearance of the clinical features of ARF. The exceptions are chorea and indolent carditis, which may follow prolonged latent periods lasting up to 6 months.</p>\r\n ",
      "correct_choice_id": 151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Most likely erythema multiforme</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Included in jones criteria as minor criteria</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Usually spares the face.</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6 years old male from Bihar presents with fever, migratory polyarthritis and following skin lesions and new onset palpitation with dyspnoea on exertion. Which of the following is correct about these skin lesions?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250110d8647f20-67ca-4ae4-b196-a540cd6ee7e5.jpg\"></span></p>",
      "unique_key": "DT1295967",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295967,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250110be8cc71b-4432-4b56-a04d-fad1d700dbdc.jpg\">\r\n<ul>\r\n<li>The skin lesions are likely <strong>erythema marginatum</strong>.</li>\r\n<li>Erythema Marginatum: which begins as pink macules that clear centrally, leaving a serpiginous, spreading edge. The rash is evanescent, appearing and disappearing before the examiner's eyes. It occurs usually on the trunk, sometimes on the limbs, but almost never on the face.</li>\r\n</ul>\r\n<p>Other major clinical features included in the Jones Criteria:</p>\r\n<ul>\r\n<li>Cardiac Involvement-most common clinical manifestation seen in up-to 75% cases. The mitral valve is almost always affected, sometimes together with the aortic valve, isolated aortic valve</li>\r\n<li>In echocardiography This diastolic image demonstrates leaflet thickening, restriction of the anterior mitral valve leaflet tip and doming of the body of the leaflet toward the interventricular septum. The characteristic echo finding of mitral stenosis secondary to Acute Rheumatic fever is described as a \"hockey stick\" or an \"elbow\" deformity.</li>\r\n<li>The characteristic manifestation of carditis in previously unaffected individuals is mitral regurgitation (most common lesion in acute rheumatic fever) sometimes accompanied by aortic regurgitation. Myocardial inflammation may affect electrical conduction pathways, leading to P-R interval prolongation (first-degree atrioventricular block or rarely higher-level block) and softening of the first heart sound.</li>\r\n<li>A diagnosis of definite RHD on screening echocardiography should lead to commencement of secondary prophylaxis</li>\r\n</ul>\r\n<p>JOINT INVOLVEMENT</p>\r\n<ul>\r\n<li>Polyarthritis is typically migratory, moving from one joint to another over a period of hours. ARF almost always affects the large joints-most commonly the knees, ankles, hips, and elbows-and is asymmetric.</li>\r\n<li><strong>The joint manifestations of ARF are highly responsive to salicylates and other nonsteroidal anti-inflammatory drugs (NSAIDs). Indeed, joint involvement that persists for more than 1 or 2 days after starting salicylates is unlikely to be due to ARF.</strong></li>\r\n</ul>\r\n<p>CHOREA</p>\r\n<ul>\r\n<li>Sydenham's chorea commonly occurs in the absence of other manifestations, follows a prolonged latent period after group A streptococcal infection, and is found mainly in females. More than 50% of patients presenting with chorea have carditis.</li>\r\n</ul>\r\n<p>SKIN MANIFESTATIONS</p>\r\n<ul>\r\n<li>erythema marginatum-described above.</li>\r\n<li>Subcutaneous nodules occur as painless, small (0.5-2 cm), mobile lumps beneath the skin overlying bony prominences, particularly of the hands, feet, elbows, occiput, and occasionally the vertebrae. They are a delayed manifestation, appearing 2-3 weeks after the onset of disease, last for just a few days up to 3 weeks, and are commonly associated with carditis.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Carditis</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Monoarthritis</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Chorea</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythema Marginatum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are included as major criteria in jones criteria for diagnosis of acute Rheumatic fever in low risk population except?</span></p>",
      "unique_key": "DT1295968",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295968,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>In low risk population only Polyarthritis is included in the major criteria while in moderate to high risk population both Monoarthritis and polyarthritis is included. </strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250110f9b6fa2e-8276-4911-bf17-c7d6439f4b7b.jpg\">\r\n ",
      "correct_choice_id": 172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Till 20 years of age (10 years of prophylaxis)</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Till 40 years of age</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Till 21 years of age</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Till 25 years of age</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">10 years old girl presents with slowly progressive dyspnoea since last 2 years. Screening echocardiography indicates presence of rheumatic Mitral stenosis. How long will be the secondary prophylaxis given in this patient?</span></p>",
      "unique_key": "DT1295972",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295972,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Secondary Prophylaxis in Acute Rheumatic Fever:</strong></p>\r\n<ul>\r\n<li>The mainstay of controlling ARF and RHD is secondary prevention. The Best antibiotic for secondary prophylaxis is benzathine penicillin G (1.2 million units, or 600,000 units if &le;27 kg) delivered every 4 weeks. It can be given every 3 weeks, or even every 2 weeks, to persons considered to be at particularly high risk, although in settings where good compliance with an every- 4-week dosing schedule can be achieved, more frequent dosing is rarely needed. Oral penicillin V (250 mg) can be given twice daily instead but is less effective than benzathine penicillin G. <strong>Penicillin-allergic patients can receive erythromycin (250 mg) twice daily.</strong></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250110a78f45b7-64bc-49be-8644-fe78c7103f90.jpg\">\r\n ",
      "correct_choice_id": 182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Sjogren syndrome</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Rheumatoid arthritis</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Systemic lupus erythematosus.</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Systemic sclerosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40 years old female complains of dry eyes and dry mouth for last 6 months. She also complains of polyarthralgia. Investigations shows Antinuclear antibody positive with SSA/Ro60 antibody high titer antibody positivity. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1295974",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295974,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Sjogren's syndrome is a prototype autoimmune disease characterized by lymphocytic infiltration of the exocrine glands resulting in xerostomia, dry eyes (keratoconjunctivitis sicca), and profound B-cell hyperactivity.</li>\r\n<li>Displays high probability of the development of lymphoma.</li>\r\n<li>Middle-aged women (female-to-male ratio 10-20:1) are primarily affected.</li>\r\n<li>Intermittent or persistent enlargement of the parotid or other major salivary glands occurs in two-thirds of patients with Sjogren's syndrome. Diagnostic tests include sialometry and several imaging techniques, including ultrasound, MRI, and magnetic resonance sialography of the major salivary glands. In particular, salivary gland ultrasound is an emerging tool of both diagnostic and prognostic utility.</li>\r\n<li><strong>Biopsy of the labial minor salivary gland allows histopathologic confirmation of focal lymphocytic infiltrates.</strong></li>\r\n<li>Ocular involvement is the other major manifestation of Sjogren's syndrome. Patients usually report a sandy or gritty feeling under the eyelids. <strong>Schirmer's test</strong> is used for Diagnostic evaluation of keratoconjunctivitis sicca.</li>\r\n</ul>\r\n<p>Other tests for keratoconjunctivitis sicca includes determination of tear composition by tear breakup time or tear lysozyme content, and <strong>slit-lamp examination of the cornea and conjunctiva after Lissamine green or Rose Bengal</strong> staining that reveals punctuate corneal and bulbar conjunctival ulcerations and attached filaments.</p>\r\n<p><strong>Autoantibodies in Sjogren Syndrome:</strong></p>\r\n<ul>\r\n<li>In two-thirds of patients, elevated erythrocyte sedimentation rate, hypergammaglobulinemia, antinuclear antibodies, rheumatoid factors, and antibodies <strong>against Ro52/Ro60 and La autoantigens</strong> (Most common antibody in Sjogren Syndrome) are detected.</li>\r\n</ul>\r\n<p><strong>Rare antibodies:</strong></p>\r\n<ul>\r\n<li>Anticentromere autoantibodies are present in Sjogren's patients with a clinical picture similar to that of limited scleroderma</li>\r\n<li>Antimitochondrial antibodies may connote liver involvement in the form of auto-immune cholangitis.</li>\r\n<li>Autoantibodies to 21-hydroxylase.</li>\r\n<li>Anti-citrullinated antibody</li>\r\n<li><strong>Anticalponin-3 antibody associated with peripheral neuropathy.</strong></li>\r\n</ul>\r\n ",
      "correct_choice_id": 191,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Systemic Lupus Erythematosus</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Sjogren syndrome</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Rheumatoid arthritis</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Antiphospholipid syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is most common autoimmune cause of renal Tubular acidosis?</span></p>",
      "unique_key": "DT1295975",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295975,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Extraglandular involvement in Sjogren syndrome</strong></p>\r\n<ul>\r\n<li>Seen in 1/3<sup>rd</sup> of patients</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501109e152030-5e94-494f-b4f3-c2d3580be52f.jpg\">\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250110b350b1c7-fc00-477f-bef0-237049aa0b48.jpg\">\r\n ",
      "correct_choice_id": 202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Diffuse large B cell lymphoma</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Follicular lymphoma</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Mantle cell lymphoma</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Marginal Zone B Lymphoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is most common Lymphoma in Sjogren syndrome?</span></p>",
      "unique_key": "DT1295976",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295976,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Lymphoma in Sjogren Syndrome:</strong></p>\r\n<ul>\r\n<li>Sjogren syndrome has the highest risk of development out of all autoimmune diseases.</li>\r\n</ul>\r\n<p>Risk factors for lymphoma development in Sjogren syndrome:</p>\r\n<ul>\r\n<li>Tongue atrophy</li>\r\n<li>Persistent parotid gland enlargement,</li>\r\n<li>Purpura</li>\r\n<li>Mixed type II cryoglobulinemia</li>\r\n<li>low serum C4 complement levels,</li>\r\n<li>Autoantibodies (rheumatoid factor, anti-Ro52, anti-Ro60, anti-La), and extensive lymphocytic infiltration in minor salivary gland.</li>\r\n</ul>\r\n<p><strong>Most lymphomas are extranodal, low-grade, marginal zone B cell Lymphoma.</strong></p>\r\n ",
      "correct_choice_id": 214,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}